All about nafithromycin, first antibiotic developed in India against deadly, drug-resistant bacteria

India reports nearly 40 lakh communities acquired bacterial pneumonia every year. Nearly 20-30 percent of these cases do not respond to existing antibiotics. For all these cases, the drug promises to be a game-changer
---------------------------------------------------------------------------------------------
Ad-lite experience, exclusive content, special privileges & more – Subscribe to ThePrint for Special benefits: https://theprint.in/subscribe/

---------------------------------------------------------------------------------------------
Connect with ThePrint
» Subscribe to ThePrint: https://theprint.in/subscribe/
» Subscribe to our YouTube Channel: https://bit.ly/3nCMpht
» Like us on Facebook:   / theprintindia  
» Tweet us on Twitter:   / theprintindia  
» Follow us on Instagram:   / theprintindia  
» Find us on LinkedIn :   / theprint  
» Subscribe to ThePrint on Telegram: https://t.me/ThePrintIndia
» Find us on Spotify: https://spoti.fi/2NMVlnB
» Find us on Apple Podcasts: https://apple.co/3pEOta8